Bausch Health Companies | VRX - Trade Creditors

Stock Price
7.62
Daily Change
-0.07 -0.91%
Monthly
8.55%
Yearly
1.74%
Q2 Forecast
7.53

Bausch Health Companies reported $600M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Amgen USD 20.89B 1.25B Dec/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Bausch Health Companies USD 600M 16M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Danaher USD 1.79B 54M Mar/2026
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 715M 93M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Phibro Animal Health USD 133.3M 2.7M Dec/2025
Prestige Brands USD 42.95M 1.02M Dec/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Zoetis USD 487M 77M Dec/2025